Finerenone emerges as a promising treatment for patients with diabetes and chronic kidney disease, significantly reducing cardiovascular and renal risks.
Andy Dang, PharmD Candidate
Advertisement
Andy Dang is a PharmD candidate at the University of Houston College of Pharmacy in Texas.
Articles by Andy Dang, PharmD Candidate
Advertisement
Latest Updated Articles
Finerenone and the Future of Diabetes-Related Kidney CarePublished: July 15th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Controversial 340B Rebate Pilot Program Is Moving Forward
2
Striking the Balance: Evidence-Based versus Defensive Medicine
3
Researchers Identify Key Lipid Pathways That Influence Alzheimer’s Progression
4
Carefully Consider Ethical Implications of Artificial Intelligence Use in Pharmacy
5
